| 1 |
Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, Naar J, Smalcova J, Hubatova M, Hromadka M, Volovar S, Seyfrydova M, Jarkovsky J, Svoboda M, Linhart A, Belohlavek J; ECMO-CS Investigators. Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial. Circulation 2023;147:454-64. [PMID: 36335478 DOI: 10.1161/CIRCULATIONAHA.122.062949] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 2 |
Varshney AS, Berg DD, Zhou G, Sinnenberg L, Hirji S, DeFilippis EM, Mallidi HR, Morrow DA, Rinewalt D, Givertz MM. Bridging strategies and cardiac replacement outcomes in patients with acute decompensated heart failure-related cardiogenic shock. Eur J Heart Fail 2023. [PMID: 36597721 DOI: 10.1002/ejhf.2762] [Reference Citation Analysis]
|
| 3 |
Siddiqi HK, Defilippis EM, Biery DW, Singh A, Wu WY, Divakaran S, Berman AN, Rizk T, Januzzi JL, Bohula E, Stewart G, Carli MD, Bhatt DL, Blankstein R. Mortality and Heart Failure Hospitalization Among Young Adults With and Without Cardiogenic Shock After Acute Myocardial Infarction. J Card Fail 2023;29:18-29. [PMID: 36130688 DOI: 10.1016/j.cardfail.2022.08.012] [Reference Citation Analysis]
|
| 4 |
Lozada Martinez ID, Bayona-gamboa AJ, Meza-fandiño DF, Paz-echeverry OA, Ávila-bonilla ÁM, Paz-echeverry MJ, Pineda-trujillo FJ, Rodríguez-garcía GP, Covaleda-vargas JE, Narvaez-rojas AR. Inotropic support in cardiogenic shock: who leads the battle, milrinone or dobutamine? Annals of Medicine and Surgery 2022. [DOI: 10.1016/j.amsu.2022.104763] [Reference Citation Analysis]
|
| 5 |
Olarte N, Rivera NT, Grazette L. Evolving Presentation of Cardiogenic Shock: A Review of the Medical Literature and Current Practices. Cardiol Ther. [DOI: 10.1007/s40119-022-00274-6] [Reference Citation Analysis]
|
| 6 |
Jung RG, Simard T, Di Santo P, Hibbert B. Transcatheter edge-to-edge repair in patients with mitral regurgitation and cardiogenic shock: a new therapeutic target. Curr Opin Crit Care 2022;28:426-33. [PMID: 35856980 DOI: 10.1097/MCC.0000000000000952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Zeng P, Yang C, Chen J, Fan Z, Cai W, Huang Y, Xiang Z, Yang J, Zhang J, Yang J. Comparison of the Efficacy of ECMO With or Without IABP in Patients With Cardiogenic Shock: A Meta-Analysis. Front Cardiovasc Med 2022;9:917610. [PMID: 35872892 DOI: 10.3389/fcvm.2022.917610] [Reference Citation Analysis]
|
| 8 |
Liu J, Tang L, Lu Q, Yu Y, Xu Q, Zhang S, Chen Y, Dai W, Li J. Plasma Quantitative Lipid Profiles: Identification of CarnitineC18:1-OH, CarnitineC18:2-OH and FFA (20:1) as Novel Biomarkers for Pre-warning and Prognosis in Acute Myocardial Infarction. Front Cardiovasc Med 2022;9:848840. [DOI: 10.3389/fcvm.2022.848840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Narayan S, Petersen TL. Uncommon Etiologies of Shock. Critical Care Clinics 2022;38:429-41. [DOI: 10.1016/j.ccc.2021.11.009] [Reference Citation Analysis]
|
| 10 |
Räpple D. ECLS im kardiogenen Schock. ECMO 2022. [DOI: 10.1007/978-3-662-66677-7_5] [Reference Citation Analysis]
|
| 11 |
Bhatt AS, Berg DD, Bohula EA, Alviar CL, Baird-Zars VM, Barnett CF, Burke JA, Carnicelli AP, Chaudhry SP, Daniels LB, Fang JC, Fordyce CB, Gerber DA, Guo J, Jentzer JC, Katz JN, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Nativi-Nicolau J, Phreaner N, Roswell RO, Sinha SS, Jeffrey Snell R, Solomon MA, Van Diepen S, Morrow DA. De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry. J Card Fail 2021;27:1073-81. [PMID: 34625127 DOI: 10.1016/j.cardfail.2021.08.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
